-

Executive War College Discusses Distress of Clinical Laboratory Industry as COVID-19 Pandemic Disrupts Supply Chain and Health Insurers Deny Payment for SARS-CoV-2 Tests

AUSTIN, Texas--(BUSINESS WIRE)--Remarkable things are happening as the nation’s medical laboratories and anatomic pathology groups answer the challenges of the COVID-19 pandemic and the need for ever-greater numbers of SARS-CoV-2 tests. Despite acute shortages of essential test kits and supplies, many labs are adding COVID-19 test capacity.

This is one finding from the opening sessions of the 2020 Virtual Executive War College on Laboratory Management, which started August 4 and is delivering 3 or weekly sessions over the next 10 weeks. All sessions are available on demand. Lab managers and pathologists can still register to participate.

Upcoming are two essential presentations by nationally recognized experts on healthcare strategy and managed care trends involving clinical laboratory and pathology testing services:

Wed., Aug. 19, 1 PM-2 PM EDT
Strategic Directions for Healthcare and Health Insurers: What's Coming Next, How Care Delivery is Changing, and New Opportunities for Clinical Labs to Add Value - BG Porter, CEO, Accumen; Kristine Bordenave, MD, Principal, KKBordenave Consulting and formerly Chief Innovation Officer, Humana.

Tues., Aug. 25, 1 PM-2 PM EDT
Rising to the COVID-19 Challenge: How the Atrium Health Lab Team Speedily Brought Up SARS-CoV-2 Testing, Is Dealing with the Inadequate Delivery of Lab Supplies, and Managing Lab Staff Across All Testing Sites - Modena Henderson, Vice President, Laboratory; John Longshore, PhD, Director of Molecular Pathology; Linda Mirkes, Assistant Vice President, Core Laboratory and Integration; all from Atrium Health.

Strong attendance at the first sessions of the Virtual Executive War College demonstrate first that the speakers, content, and information are of immediate value to lab leaders throughout the U.S. and second, that there is support for the virtual conference concept. Currently, 400+ registrants participate in the Virtual Executive War College, with new registrations daily. The full line-up of sessions is available on-demand, 24/7.

Proving equally valuable to lab leaders and IVD marketing professionals attending the virtual event is the ability to network and interact with attendees. Executive War College’s digital platform makes it possible for any attendee to message any other attendee, invite a group of attendees to a group chat or Zoom session, or organize Zoom get-togethers on specific topics such as solving supply chain problems, getting paid for COVID-19 tests, and finding medical technologists to support expansion of SARS-CoV-2 testing.

For details on speakers and sessions and to register, visit: https://www.executivewarcollege.com.

Contacts

Shelly Hatch
512-264-7103

Industry:

The Dark Report

Release Summary
Experts discuss distress of clinical lab industry as COVID-19 pandemic disrupts supply chain and health insurers deny payment for SARS-CoV-2 tests.
Release Versions
English

Contacts

Shelly Hatch
512-264-7103

More News From The Dark Report

LabX Media Group Acquires The Dark Intelligence Group Inc, including The Dark Report and the Executive War College

AUSTIN, Texas--(BUSINESS WIRE)--The Dark Intelligence Group (TDIG) announced today that it has sold all its information services assets to LabX Media Group of Midland, Ontario, Canada. This sale involves all TDIG products and services, such as The Dark Report intelligence service, DarkDaily ebriefings, webinars, reports, and events, including the Executive War College on Diagnostic, Laboratory, and Pathology Management, the largest global conference on laboratory management for senior laborator...

Operationalizing FDA LDT Compliance: Expert Panel Reveals Essential Strategies and Actions for Meeting the 1st Reporting Milestone

AUSTIN, Texas--(BUSINESS WIRE)--Many clinical laboratories are now under the gun to achieve Phase One compliance with the Food and Drug Administration’s (FDA) LDT rule before the May 2025 deadline. Labs performing LDTs must take immediate action to protect their most important LDTs that improve patient care while generating substantial reimbursement. This is a high stakes situation for labs offering LDTs because they have only five months to secure their most valuable LDTs. To help labs underst...

Experts to Identify Essential Steps & Pitfalls to Help Clinical Laboratories Meet the Deadline to Comply with the FDA’s Laboratory Developed Test (LDT) Rule

AUSTIN, Texas--(BUSINESS WIRE)--With the first important deadline for compliance with the Food and Drug Administration’s (FDA) LDT rule only eight months away, experts urge clinical laboratories performing LDTs to take immediate action. This is essential to protect their most important LDTs that improve patient care while generating substantial reimbursement. The FDA’s final rule on Laboratory Developed Tests (LDTs) ushers in a radical overhaul of the FDA’s longstanding policy of enforcement di...
Back to Newsroom